22nd Century Group Inc
XXII
Company Profile
Business description
22nd Century Group Inc is a United States-based biotechnology company focused on utilizing alkaloid plant technologies to improve health and wellness with reduced nicotine tobacco, and hemp/cannabis. It has one operating segment; The tobacco segment is engaged in commercializing its proprietary VLNC tobacco plants and cigarette products, which contain nicotine than conventional tobacco and cigarettes, and research cigarettes sold under the brand name SPECTRUM. It derives a majority of its revenue from the tobacco segment.
Contact
321 Farmington Road
MocksvilleNC27028
USAT: +1 336 940-3769
Sector
Consumer Defensive
Stock type
Defensive
Industry
Tobacco
Fiscal Year End
31 December 2026
Employees
56
Stocks News & Analysis
stocks
What to expect from the January Fed meeting
Central bankers are likely to hold interest rates steady, but Wall Street is focused on life after Powell.
stocks
Fortescue costs outpace increasing volume
Higher diesel prices and foreign exchange hit unit cash costs.
stocks
A top global stock to buy after a big change in its forecast
Undervalued by 24%, this wide-moat stock is a buy now.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,268.50 | 94.30 | 1.03% |
| CAC 40 | 8,161.10 | 29.95 | 0.37% |
| DAX 40 | 24,933.79 | 0.71 | 0.00% |
| Dow JONES (US) | 49,412.40 | 313.69 | 0.64% |
| FTSE 100 | 10,191.34 | 42.49 | 0.42% |
| HKSE | 27,126.95 | 361.43 | 1.35% |
| NASDAQ | 23,601.36 | 100.11 | 0.43% |
| Nikkei 225 | 53,333.54 | 448.29 | 0.85% |
| NZX 50 Index | 13,510.88 | 50.14 | 0.37% |
| S&P 500 | 6,950.23 | 34.62 | 0.50% |
| S&P/ASX 200 | 8,941.60 | 96.50 | 1.09% |
| SSE Composite Index | 4,139.90 | 7.30 | 0.18% |